Fresenius SE & Co. KGaA (ETR:FRE)
44.62
+0.43 (0.97%)
Apr 17, 2026, 5:35 PM CET
Fresenius SE & Co. KGaA Employees
As of December 31, 2025, Fresenius SE & Co. KGaA had 178,583 total employees, including 131,789 full-time and 46,794 part-time employees. The number of employees decreased by 1,301 or -0.72% compared to the previous year.
Employees
178,583
Change
-1,301
Growth
-0.72%
Revenue / Employee
€147,391
Profits / Employee
€8,145
Market Cap
25.13B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 178,583 | -1,301 | -0.72% | 131,789 | 46,794 |
| Sep 30, 2025 | 177,356 | 265 | 0.15% | 177,356 | 0 |
| Jun 30, 2025 | 176,207 | 436 | 0.25% | 176,207 | 0 |
| Mar 31, 2025 | 175,202 | -15,661 | -8.21% | 175,202 | 0 |
| Dec 31, 2024 | 179,884 | -13,981 | -7.21% | 132,542 | 47,342 |
| Sep 30, 2024 | 177,091 | -16,436 | -8.49% | 177,091 | 0 |
| Jun 30, 2024 | 175,771 | -139,462 | -44.24% | 175,771 | 0 |
| Mar 31, 2024 | 190,863 | -122,949 | -39.18% | 190,863 | 0 |
| Dec 31, 2023 | 193,865 | -123,055 | -38.83% | 193,865 | 0 |
| Sep 30, 2023 | 193,527 | -126,164 | -39.46% | 193,527 | 0 |
| Jun 30, 2023 | 315,233 | -3,414 | -1.07% | 315,233 | 0 |
| Mar 31, 2023 | 313,812 | -3,430 | -1.08% | 313,812 | 0 |
| Dec 31, 2022 | 316,920 | 842 | 0.27% | 316,920 | 0 |
| Sep 30, 2022 | 319,691 | 4,839 | 1.54% | 319,691 | 0 |
| Jun 30, 2022 | 318,647 | 5,913 | 1.89% | 318,647 | 0 |
| Mar 31, 2022 | 317,242 | 6,400 | 2.06% | 317,242 | 0 |
| Dec 31, 2021 | 316,078 | 4,809 | 1.54% | 316,078 | 0 |
| Sep 30, 2021 | 314,852 | 5,738 | 1.86% | 314,852 | 0 |
| Jun 30, 2021 | 312,734 | 9,888 | 3.27% | 312,734 | 0 |
| Mar 31, 2021 | 310,842 | 11,248 | 3.75% | 310,842 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius Medical Care AG | 109,698 |
| Bayer Aktiengesellschaft | 87,280 |
| Siemens Healthineers AG | 73,800 |
| Merck KGaA | 59,077 |
| Fielmann Group AG | 24,363 |
| Drägerwerk AG & Co. KGaA | 16,495 |
| Sartorius Aktiengesellschaft | 14,042 |
| Ottobock SE & Co. KGaA | 10,365 |
Fresenius SE & Co. KGaA News
- 11 days ago - EQS-AGM: Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting in Frankfurt am Main on 22.05.2026 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution - Wallstreet:Online
- 18 days ago - EQS-DD: Fresenius SE & Co. KGaA: Pierluigi Antonelli, buy - Wallstreet:Online
- 18 days ago - EQS-DD: Fresenius SE & Co. KGaA: Robert Möller, buy - Wallstreet:Online
- 4 weeks ago - EQS-DD: Fresenius SE & Co. KGaA: Sara Hennicken, buy - Wallstreet:Online
- 4 weeks ago - Glenmark Pharmaceuticals to launch Potassium Phosphates Injection in March 2026 - Business Upturn
- 1 year ago - Fresenius posts profit beat in first quarter, confirms outlook - Reuters
- 1 year ago - Fresenius SE Raises Guidance After Strong Kabi, Helios Performances - WSJ
- 2 years ago - Healthcare group Fresenius tops Q4 operating profit expectations - Reuters